Sort
48,018 grants matching “immunotherapy”
Chemotherapy-free cure of hemoglobin disorders through base editing
$766,048Daniel Evan Bauer · Boston Children'S Hospital · R01 · FY2025 · HL
Beta-2 adrenergic signaling in immune homeostasis and reconstitution
$766,025Xuefang Cao · University Of Maryland Baltimore · R01 · FY2023 · HL
Beta-2 adrenergic signaling in immune homeostasis and reconstitution
$766,025Xuefang Cao · University Of Maryland Baltimore · R01 · FY2022 · HL
Beta-2 adrenergic signaling in immune homeostasis and reconstitution
$766,025Xuefang Cao · University Of Maryland Baltimore · R01 · FY2025 · HL
Clinical Protocoal and Data Management
$765,997Carrie B Lee · Univ Of North Carolina Chapel Hill · P30 · FY2024 · CA
Molecular mechanism of antigen editing by Class-I MHC Chaperones
$765,605Nikolaos Sgourakis · University Of California Santa Cruz · R01 · FY2019 · AI
Targeting Neuroblastoma with armed T cells
$765,563Lawrence G Lum · University Of Virginia · R01 · FY2017 · CA
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
$765,544Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2017 · CA
Immune reconstitution following autologous and allogeneic stem cell transplant
$765,402Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Baltimore Acute Hepatitis C Cooperative Center
$765,313Andrea L Cox · Johns Hopkins University · U19 · FY2011 · AI
Fcgamma receptor-mediated suppression of immunodeficiency virus replication
$765,191David T Evans · University Of Wisconsin-Madison · R01 · FY2017 · AI
Fcgamma receptor-mediated suppression of immunodeficiency virus replication
$765,191David T Evans · University Of Wisconsin-Madison · R01 · FY2018 · AI
Fcgamma receptor-mediated suppression of immunodeficiency virus replication
$765,191David T Evans · University Of Wisconsin-Madison · R01 · FY2019 · AI
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
$765,000Zachary Scott Morris · University Of Wisconsin-Madison · U01 · FY2020 · CA
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
$765,000Zachary Scott Morris · University Of Wisconsin-Madison · U01 · FY2018 · CA
Core Center for Translational Addiction Sciences
$765,000Kathryn A. Cunningham · University Of Texas Med Br Galveston · P30 · FY2010 · DA
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
$765,000Zachary Scott Morris · University Of Wisconsin-Madison · U01 · FY2021 · CA
Core Center for Translational Addiction Sciences
$765,000Kathryn A. Cunningham · University Of Texas Med Br Galveston · P30 · FY2009 · DA
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
$765,000Zachary Scott Morris · University Of Wisconsin-Madison · U01 · FY2019 · CA
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
$765,000Zachary Scott Morris · University Of Wisconsin-Madison · U01 · FY2022 · CA
Assessing ADCC and Fc-mediated Protection against HIV
$764,967David T Evans · University Of Wisconsin-Madison · R01 · FY2021 · AI
Glucocorticoids and T cell development and function
$764,931Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Mechanisms of protection against shigellosis in children
$764,815Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2023 · AI
Mechanisms of protection against shigellosis in children
$764,815Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2024 · AI
Mechanisms of Clinical Reactivity or Tolerance to Mouse Allergen
$764,726Wayne G Shreffler · Massachusetts General Hospital · R01 · FY2014 · AI